Kien Pham, Ph.D.
Affiliations: | 2013 | Pharmacology and Therapeutics | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Pharmacology, Oncology, Molecular BiologyGoogle:
"Kien Pham"Parents
Sign in to add mentorJeffrey K. Harrison | grad student | 2013 | UF Gainesville | |
(Functions and therapeutic targeting of chemokines and chemokine receptors in glioblastoma progression.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Pham K, DeFina S, Wang H. (2021) E-Cigarettes Promote Macrophage-Tumor Cells Crosstalk: Focus on Breast Carcinoma Progression and Lung Metastasis. Exploratory Research and Hypothesis in Medicine. 6: 60-66 |
Pham K, Huynh D, Le L, et al. (2020) E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Letters |
Brown M, Zhang W, Yan D, et al. (2020) The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. Plos One. 15: e0226917 |
Wang X, Wu Q, Pham K, et al. (2020) Abstract 1811: Sorafenib-mediated apoptotic and autophagic cell death is increased by carnosic acid and a vitamin D2 analog in hepatocellular carcinoma (HCC) Cancer Research. 80: 1811-1811 |
Wu Q, Wang X, Pham K, et al. (2019) Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination. The Journal of Steroid Biochemistry and Molecular Biology. 105524 |
Sivaram N, McLaughlin PA, Han HV, et al. (2019) Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. The Journal of Clinical Investigation. 130 |
Chan N, Riedlinger G, Lu S, et al. (2019) Abstract P1-15-14: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of triple negative breast cancer Cancer Research. 79 |
Sivaram N, McLaughlin P, Jiang Y, et al. (2019) Abstract 522: PI3K/Akt signaling in tumor cells promotes immune evasion by limiting infiltration, recognition and killing by T cells Cancer Research. 79: 522-522 |
Paratala BS, Chung JH, Williams CB, et al. (2018) RET rearrangements are actionable alterations in breast cancer. Nature Communications. 9: 4821 |
Wu Q, Pi L, Le Trinh T, et al. (2017) A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy |